2020 – Present:Professor ofPharmaceutical Administration,Master supervisor, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology
2013 -2014:A state-sponsored visiting scholar in the Department of Pharmaceutical Systems and Policy of School of Pharmacy of West Virginia University, USA.
Main courses taughtfor undergraduates, international students and postgraduates of pharmacy
Pharmaceutical Administration, Pharmaceutical Ethics, Hospital Pharmacy Management
Main research directions:
Policy system of orphan drug and disaster medicine in China, drug policy evaluation, and pharmacoeconomic analysis
Membership in professional societies:
Member of the Pharmaceutical Administration Professional Committee of the Chinese Pharmaceutical Association
Member of the China Pharmaceutical Regulatory and Management Research Association
Research projects:
Over two projects of National Natural Science Foundation of China, one provincial teaching reform project were presided.
Publications:
More than 50 papers in domestic and foreign core journals were published.
1.Li WeiJie,Xia MeiJun,Gong ShiWei*,Ding YuFeng. Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China.[J]. Current medical science,2021,: doi:10.1007/S11596-021-2412-4.
2.Shiwei Gong,Dehe Li,Dong Dong. How Do Patients and Doctors Perceive Medical Services for Rare Diseases Differently in China? Insights from Two National Surveys[J]. International Journal of Environmental Research and Public Health,2020,17(16): doi:10.3390/ijerph17165961.
3.Dong Dong,Chung Roger Yat Nork,Chan Rufina H. W.,Gong Shiwei*,Xu Richard Huan. Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China[J]. Orphanet Journal of Rare Diseases,2020,15(1):doi:10.1186/s13023-020-01587-2.
4.Gong, Shiwei, Cai, HongBing, Ding, Yufeng, et al. The availability, price and affordability of antidiabetic drugs in Hubei province, China[J]. Health policy and planning,2018,33(8):937-947. DOI:10.1093/heapol/czy076.
5.Xiong Xiaolei,Zhang Zhiguo,Ren Jing,Zhang Jie,Pan Xiaoyun,Zhang Liang,Gong Shiwei i*,Jin Si. Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China.[J]. PloS one,2018,13(3): doi:10.1371/journal.pone.0193273.
6.Gong Shiwei,Wang Yingxiao,Pan Xiaoyun,Zhang Liang,Huang Rui,Chen Xin,Hu Juanjuan,Xu Yi,Jin Si. The availability and affordability of orphan drugs for rare diseases in China.[J]. Orphanet journal of rare diseases,2016,11: doi:10.1186/s13023-016-0392-4.
7.Gong Shiwei,Jin Si. Current progress in the management of rare diseases and orphan drugs in China[J]. Intractable & Rare Diseases Research,2012,1(2):doi:10.5582/irdr.2012.v1.2.45
Awards:
"Excellent Head Teacher of Love and Dedication" in Hubei Province
The second prize of Hubei Science and Technology Progress Award
Chinese Medical Papers Award in 2016.
Business Address:
Rm317, Second building ofSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, 430030
E-mail:shwgong@hust.edu.cn
